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The objective of the study is to investigate whether the Hibiscus aethiopicus L. plant has neutralization activity against venoms of
twoclinicallyimportantsnakes.TheH.aethiopicuswasdriedandextractedwithwater.Diﬀerentassayswereperformedtoevaluate
the plant’s acute toxicity and its anti-snake venom activities. The results showed that H. aethiopicus extract alone had no eﬀect on
the viability of C2C12 muscle cells, but signiﬁcantly (P<. 05) protected muscle cells against the toxic eﬀects of E. ocellatus venom
at 55, 150, and 300μg/mL. The maximum protective eﬀect of the extract was exhibited at 75μg/mL. The extract signiﬁcantly
(P<. 001) inhibited the cytotoxic eﬀects of E. ocellatus venom at 300μg/mL. All rabbits (n = 10) and guinea pigs (n = 10) were
alive after the two weeks of given the lethal dosage 16g/Kg of the H. aethiopicus extract herbal solution. No abnormal behaviour
was observed of both groups of animals. All guinea pigs (n = 3) treated with venoms alone (5mg/kg) died. However, all guinea
pigs(n = 21)treatedwithvenom(5mg/kg)andtheextract(400to1000mg/kg)survived.Guinea pigs(n = 3)treatedwithNaja n.
nigricollis venom alone (2.5mg/kg) and guinea pigs (n = 21) venom with the extract (400 to 1000mg/kg) died. The H. aethiopicus
completely (100%) blocked the haemorrhagic activity of E. ocellatus in the egg embryo at 3.3mg/mL of extract. These ﬁndings
suggest that H. aethiopicus may contain an endogenous inhibitor of venom-induced haemorrhage.
1.Introduction
Snake bite remains a public health problem in many
countries even though; it is diﬃcult to be precise about the
actual number of cases. It is estimated that the true incidence
of snake envenomation could exceed 5 million per year [1].
About 100,000 of these develop severe squeal [1]. The global
disparity in the epidemiological data reﬂects variations in
healthreporting accuracyaswell as the diversity of economic
and ecological conditions [1]. Accurate records to determine
the exact epidemiology or even mortality of snake bite
cases are generally unavailable [2]. Hospital records fall
far short of the actual number, owing to dependence on
traditional healers and practitioners of witchcraft, especially
in developing countries. It has been reported that in most
developing countries, up to 80% of individuals bitten by
snakes ﬁrst consult traditional practitioners before visiting a
medical centre [3, 4]. Owing to the delay, several victims die
during transit to the hospital.
Envenoming by snakes such as E. ocellatus and Naja n.
nigricollis is responsible for several clinical complications of
severe systemic and local pathology. For example, E. ocellatus
leads to inﬂammation (such as swelling, blistering, and
necrosis)andhaemorrhages[5]duetobothmetalloproteases
and ecarin (an enzyme that activates prothrombin) [6]. On
the other hand envenoming by Naja n. nigricollis induced
clinical complications diﬀerent from that caused by E. ocella-
tus. These include local necrosis, haemorrhage, complement
depletion [7], and respiratory arrest or paralysis [5, 8].
Moreover, the venom of the Naja n. nigricollis consists of
phospholipase A2 (an anticoagulant enzyme which inhibits
the prothrombinase complex by its binding to coagulation2 Journal of Toxicology
factor Xa) [9, 10] and cardiotoxin [11]. Furthermore, in
some cases envenoming by Naja n. nigricollis can induce
corneal ulceration and anterior uveitis [12, 13].
Although an intravenous administration of antivenom,
prepared from IgG of venom-immunised horses or sheep,
is an eﬀective treatment for systemic envenoming [14], the
clinicalconsensusisthatantivenomisoflimitedeﬀectiveness
against the eﬀects of local envenoming that develop rapidly
after a bite [15]. Such eﬀects include severe pain, oedema,
localized haemorrhage, and necrosis [16] which often results
in permanent scarring and deformity. The ineﬀectiveness of
antivenom in treating local envenoming has been attributed
to the rapid activity of the toxins and the inability of
antivenom IgG to cross the blood/tissue barrier [17, 18].
Despite their smaller size, F(ab2)2 and Fab fragments of
IgG are also ineﬀective against the local eﬀects of envenom-
ing, whether administered by intravenous or intramuscular
routes [19, 20]. Research to develop a treatment for local
envenoming is therefore a clinical priority and has focused
ontheapplicationofnatural[21]orsyntheticinhibitors[22]
of snake venom potent molecules.
The use of plant remedies to treat snakebite victims
in rural areas and poor communities in the developing
c o u n t r i e si sac o m m o np r a c t i c e .T h en a t i v e sw h oa r e
predominantly rural farmers come in contact with snakes
during their farming engagements. Due to high cost of
hospital treatment and unavailability of antivenoms, most
often the rural people ﬁnd it more convenient to consult
native doctors who are acclaimed for curing snakebite
patients. Anecdotal evidence abounds to indicate that plant
remedies used by the native doctors are eﬀective, and there
appearstobeahighrateofsurvivalamongsnakebitepatients
advanced clinical stages of venom toxicity.
The present study aims to study the anti-snake venom
activities of a local plant, Hibiscus aethiopicus L. which is
brought over 200 years ago from Africa and regrown in
Bani-Hushash region, Sana’a Yemen [23]. This plant was
found to be used by traditional healers in Bani-Hushash
East of Sana’a to treat patients bitten by snakes and/or
scorpions [23]. Although Hibiscus aethiopicus L. has long
been used as a medicinal plant by traditional healers, the
validity of the claims made for this plant has not been tested
scientiﬁcally. In other words Hibiscus aethiopicus like many
other important plant species, has not been investigated
adequately in terms of its anti-snake venom activities. We
report in this study and for the ﬁrst time, how signiﬁcant
this folk tradition medicine is (i.e., Hibiscus aethiopicus)t o
neutralized snake venom activity, of a typical and highly
poisonous snakes such as the West African E. ocellatus snake.
2.MaterialsandMethods
2.1. Plant Material. The whole plant of Hibiscus aethiopicus
was collected with assistance of a traditional healer, from
Bani-Hushaiesh. Authentication and the taxonomic identiﬁ-
cation of plant materials was conﬁrmed by Dr. A. Wadieh,
Department of Botany, Naser College, in Lahj Governorate,
University of Aden, Republic of Yemen. A voucher sample
was then deposited in the herbarium of the Department of
Botany.Onekilogramofthefreshplantwasdriedundermild
sunshine. The dried sample was then pulverized and stored
in plastic bags.
2.2. Extraction of Plant Material. The air-dried and pulver-
ized plant material (200g) was extracted with 250mL water
by using a shaking water-bath at 70◦Cf o r2h o u r s .T h e
extractionwithwaterwasrepeatedthreetimes. Theobtained
water extract was ﬁltered and evaporated using a rotary
evaporator and freeze dryer to give the crude dried extract.
The dried extract was stored at 20◦C until used.
2.3. Source of Venoms. The venom of E. ocellatus was kindly
provided by Dr. R. Harrison—the Liverpool School of
Tropical Medicine, Liverpool, UK. The venom of Naja n.
nigricollis was purchased from Sigma Aldrich ltd (Category
No. V8377).
2.4. Ethics. Ethical approval for this study was obtained from
therelevantEthicsandResearchCommitteeoftheUniversity
of Science and Technology, Sana’a, Yemen. All experiments
that involve animals were performed according to ethical
standards.
2.5. Cytotoxicity Assay. The eﬀects of Hibiscus aethiopicus
extract and venoms (E. ocellatus and Naja n. nigricollis)o n
cultured C2C12 myoblast cells were investigated separately
following the tetrazolium salt (MTT) assay method [24].
Cells were seeded in 96 well microtitre plates (104 cells per
well in 100μL medium) and allowed to attach and reach log
phase of growth (24h). Various concentrations of Hibiscus
aethiopicus extract (75, 150, and 300μg/mL) with or without
venom (15μg/mLofE.ocellatus,30μg/mLNajan.nigricollis)
were added to each well in 100μL medium. The cells were
incubated the cells at 37◦C 18h. Ten microliters (10μL) of
MTT (5mg/mL) was added to each well and plates were
incubated for 4h, at 37◦C, after which the medium was
aspirated from the wells and a volume of 150μLD M S Ow a s
added per well to solubilise the cells. The microplates were
shaken for 2minutes at 400rpm on a microplate shaker. The
optical density was measured at 570nm using a Dynex MRX
platereader(MTXLabSystems).Theresultswerestatistically
analysed using ANOVA and Student’s t-test.
2.6. Antihemorrhagic Test. One-day-old fertile eggs obtained
from a local hatchery were incubated till day 4 at 38◦C. The
eggs were cracked on day 4 into Clingﬁlm hammocks follow-
ing a standard method [21, 25] and incubated further till day
6. Discs of 2mm diameter cut from ﬁlter paper (Whatman
No. 2) were impregnated with a standard hemorrhagic dose
(SHD) of E. ocellatus venom (3μg/1.5μL) alone or venom
and various concentrations (2.5, 5.0, 7.5, and 10μg/1.5μL)
of Hibiscus aethiopicus extract. The discs were placed on
the yolk sac membrane over a major bilateral vein and left
for 3h for hemorrhagic corona to form. The corona was
measured with a ruler. Control experiments were performed
with the buﬀered saline solution used to prepare the extractJournal of Toxicology 3
and venom solutions. Readings were taken in triplicate. The
minimum concentration required to abolish haemorrhage
was recorded as the minimum eﬀective neutralizing dose
(MEND).
2.7. Evaluations of Acute Toxicity of Hibiscus aethiopicus
Extract In Vivo Using Both “Oral” and “Intraperitoneal”
Routes. Two in vivo assays using both “oral” and “intraperi-
toneal” routes were performed to evaluate the acute toxicity
and the cumulative eﬀect “safety protection” potentialities of
the Hibiscus aethiopicus composition.
Ethical approval for this study was obtained from the
relevant Ethics and Research Committee of University of
Science and Technology, Sana’a, Yemen.
2.7.1. Oral Route Acute Toxicity. Two diﬀerent species of
animals rabbits (group-A) and guinea-pigs (group-B), were
used in the toxicity proﬁle. Animals were obtained from
a well-known animal keeper, Nuccom, Sana’a, Republic
of Yemen. Group-A included ten rabbits weighed between
800g and 1300g. Group-B included ten guinea-pigs weighed
between 300g and 900g. Both rabbits and guinea-pigs were
given diﬀerent dosages to investigate the lethal dosage as
illustrated in Tables 2 and 3.T h ee x t r a c ts o l u t i o nw a s
given orally using anesthesia at variable dosages to reach
the optimum of 16g/kg (a lethal dosage according to the
international standardisation for the classiﬁcation of sub-
stances) for each animal group. The animals were observed
for behaviour change continuously for a period of two
weeks after such administration. Observation was conducted
hourly at day 1, and during the following days, observation
was conducted 4–6 times per day. Subsequently, blood
samples for biochemical assays, alanine aminotransferase
(ALT), aspartate aminotransferase (AST), complete blood
count (CBC), and gamma glutamyl transpeptidase (GGT)
were collected. At the end of the observation period, animals
were sacriﬁced and dissected for adverse eﬀects if any based
on histopathology examination of their eyes, liver, lung, and
spleen.
2.7.2. Intra-Peritoneal Route Acute Toxicity. Intra-peritoneal
(i.p) acute toxicity test was performed instead of the oral
route. A total of 35 guinea pigs of both sexes distributed
randomly into ﬁve groups and being treated i.p. with
increasing doses (250, 500, 750, 1000, 1300, and 1600mg/kg)
of Hibiscus aethiopicus extract. The ﬁfth group served as
control and received an equivalent volume of distilled water.
Animals (i.e., guinea pigs) were observed regularly over a
period of 24h for signs of acute toxicity and death.
2.8. Evaluations of Hibiscus aethiopicus Extract In Vivo for
Anti-Snake Venom Activity
2.8.1. Administration of Both Venom and Extract after Pre
Incubation. Seventy eight adult guinea pigs of both sexes
(500–600g) were divided into four groups. Group 1 (of 3
guinea pigs) was injected with Naja n. nigricollis venom
(2.5mg/kg) alone. Group 2 was divided into twelve equal
subgroups (G2.1–G2.12) of three guinea pigs each. All of
the subgroups were injected i.p. with a mixture of Naja n.
nigricollis venom and Hibiscus aethiopicus extract (50, 75,
100, 200, 300, 400, 500, 600, 700, 800, 900, and 1000mg/kg)
accordingly after both venom and extract were incubated in
a test tube for 30minutes. Groups 3 and 4 were similar to
Groups 1 and 2 except that E. ocellatus venom (5mg/kg) was
used instead of Naja n. nigricollis. A l la n i m a l sw e r eo b s e r v e d
over the 24 hours. At the end of the observation period,
animals were sacriﬁced and their skins were dissected to
examinetheneutralisationeﬃcacyoftheHibiscusaethiopicus
extract.
2.8.2. Administration of Extracts 30 Minutes Prior to Venom
Injection. Sixty adult guinea pigs of both sexes (500–600g)
were divided into four equal groups. Group 1 (of 5 guinea
pigs) was injected with Naja n. nigricollis venom (2.5mg/kg,
i.p.). Group 2 was divided into ﬁve equal subgroups (G2.1–
G2.5) of ﬁve guinea pigs each. All of the subgroups were
injected i.p. with the same dose (2.5mg/kg, i.p.) of Naja n.
nigricollis venom 30 min after Hibiscus aethiopicus extract
wasadministeredorallyatdiﬀerentconcentrations(100,200,
300, 400, and 1000mg/kg) by gastric incubation. Groups 3
and 4 were similar to Groups 1 and 2 except that E. ocellatus
venom (5mg/kg) was used instead of Naja n. nigricollis. All
animals were observed over the period of the experiment.
3. Results
3.1.CytotoxicityAssay. TheHibiscusaethiopicusextractalone
had no eﬀect on the viability of C2C12 muscle cells, but it
signiﬁcantly(P<. 05)protectedmusclecellsagainstthetoxic
eﬀectsof E.ocellatus venom (30μg/mL) at all concentrations
of the extract tested (55, 150, and 300μg/mL) (Figure 1).
The maximum (67%) protective eﬀect of the extract was
exhibited with extract at 75μg/mL. The extract signiﬁcantly
(P<. 001) inhibited the cytotoxic eﬀects of E. ocellatus
venom only at 300μg/mL (Figure 1). On the other hand the
Hibiscus aethiopicus extract showed no eﬀect to protect the
musclecellsagainstthetoxiceﬀectsofNajan.nigricollis(data
not shown).
3.2. Antihemorrhagic Test. The Hibiscus aethiopicus totally
(100%) blocked the haemorrhagic activity of E. ocellatus
in the egg embryo at 5μg/1.5μL (3.3mg/mL) of extract
(Table 1). The MEND is 5μg/1.5μL.
3.3. Evaluations of the Systemic Acute Toxicity of the Hibiscus
aethiopicus Extract Using “Oral” Route. All animals (rabbits
and guinea pigs) were alive after the two weeks of given
the lethal dosage of 16g/Kg. No abnormal behaviour was
observed of both groups of rabbits and guinea-pigs during
the observation period. The rabbits and guinea pigs showed
normal body weight increase during the two weeks period.
Biochemical analysis showed normal range of ALT, AST,
CBC, and GGT (Table 2). Inspection of the eyes, liver, lung,
and spleen (after scariﬁcation and dissection) showed no
extraordinary signs. The results when compared to a general4 Journal of Toxicology
Table 1: Eﬀects of H. aethiopicus L. extract on the haemorrhage induced by E. ocellatus venom in the egg embryo.
Extract/venom
Concentration of
extract
(μg/1.5μL)
Haemorrhagic
zone
(mm)
Reduction from
control
∗MEND
(%)
State of embryo
(μg/1.5μL)
E. ocellatus (3μg/1.5μL) — 3.0 — All died
H. aethiopicus L. + E.o (3μg/1.5μL) 2.5 0.5 85.7 All alive
H. aethiopicus L. + E.o (3μg/1.5μL) 5.0 0.0 100.0 5 All alive
H. aethiopicus L. + E.o (3μg/1.5μL) 10.0 0.0 100.00 All alive
∗MEND: Minimum eﬀective neutralising dose; E.o: Echis ocellatus.
Table 2: Biochemical analysis for acute toxicity of the Hibiscus aethiopicus L. plant.
Group (G) ALT (Mean∗) AST (Mean∗) GGT (Mean∗)
G1: Normal (n = 4) 46 ± 4.5∗ 90 ± 2.1 2.2 ± 0.9
G2: Intoxicated control (n = 4) 71 ± 1.8 193 ± 4.1 3.4 ± 0.2
G3: Rabbits (n = 10) 50 ± 6.7∗ 143 ± 0.8 5.3 ± 0.1
G4: Guinea pigs (n = 10) 45 ± 3.2 103 ± 1.3 3.1 ± 0.7
ALT: alanine aminotransferase;
AST: aspartate aminotransferase;
GGT: gamma glutamyl transpeptidase.
Data are expressed as International Units (IU/mL); ∗Mean value Signiﬁcantly diﬀerent (P<. 05) compared with respective values (before treatment) using
paired Student’s t-test. n = number of animal. ∗All values presented are means ± SE (standard error). No statistically signiﬁcant diﬀerences were observed.
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Figure 1: Eﬀects of Hibiscus aethiopicus L. extract against the
cytotoxic actions of E. ocellatus venom on C2C12 muscle cells. E. o:
Echis ocellatus; H. A: Extract of H. aethiopicus L.
acute toxicity index were normal and no acute toxicity was
observed.
3.4. Evaluations of the Acute Toxicity of the Hibiscus aethiopi-
cus Extract Using “Intra-Peritoneal” Route. Guinea pigs
dosed intraperitoneally with Hibiscus aethiopicus extract
were initially dull with signiﬁcantly reduced movement for
10–20 minutes. However, neither death nor signs of toxicity
were observed even at the highest dose (1600mg/kg) tested.
3.5. Evaluation of Hibiscus aethiopicus Extract In Vivo for
Anti-Snake Venom Activity
3.5.1. Administration of Extracts 30 Minutes prior to Venom
Injection. All guinea pigs injected with E. ocellatus venom
(5mg/kg) alone died. However all guinea pigs injected
with both E. ocellatus venom and the plant extract (at a
concentration of 400 to 1000mg/kg) survived (Table 3).
However, all guinea pigs treated with Naja n. nigricollis
venom alone (2.5mg/kg) and/or venom with the water
extract (at a concentration of 400 to 1000mg/kg) died
(Table 3). There was no signiﬁcant diﬀerence between the
time of death in both the treated and control groups
(Table 3).
3.5.2. Administration of Both Venom and Extract after 30
Minutes Pre Incubation. All Guinea pigs treated with ven-
oms E. ocellatus 5mg/kg alone “Group 1” induced acute
haemorrhage and died (Figure 2(a)). In contrast all guinea
pigs treated with venom and the plant extract “Group 2”
at a concentration between 400 and 1000mg/kg survived
and showed no signs of acute haemorrhage (Figure 2(b)).
Moreover, all guinea pigs treated with venom and the
plant extract below 400mg/kg died. However, all of the
guinea pigs treated with Naja n. nigricollis venom 2.5mg/kg
“Group 3” alone and venom with the plant extract “Group
4” died. Although, all guinea pigs treated with a mix-
ture of Naja n. nigricollis venom and the extract after
preincubation died, the time of death was signiﬁcantly
(P<. 05) increased from 0.95 h to 5.57h in the group
treated with the mixture of extract and venom in compar-
ison with the control. There was no signiﬁcant diﬀerence
between the time of death in the treated and control
groups.Journal of Toxicology 5
Table 3: Animal status after 30 minutes prior to venom injection.
Group Venom/Extract Hibiscus aethiopicus L. extract (mg /kg)
100 200 300 400 1000
1 Nnn venom (2.5mg/kg, i.p.) alone Died Died Died Died Died
2 H. Aethiopicus + Nnn (2.5mg/kg, i.p.)∗ Died Died Died Died Died
3 E.o venom (5mg/kg) alone Died Died Died Died Died
4 H. Aethiopicus + E.o (5mg/kg)∗ Died Died Died Alive Alive
∗Venomwas injected 30 min after Hibiscus aethiopicus L. extract was administered orally by gastric incubation.
Each group has ﬁve guinea pigs. Nnn: Naja n. nigricollis; E.o: Echis ocellatus.
(a) Represent acute haemorrhage of guinea
pigs when injected (i.p.) with E. ocellatus
(5mg) venom
(b) Shows a complete venom neutralisation of guinea
pigs when treated i.p. with a mixture of E. ocellatus
v e n o m( 5m g / k g )a n dHibiscus aethiopicus L. extract
(600mg/kg) after both venom and extract were incu-
bated in a test tube for 30 minutes
Figure 2: Administration of both venom and extract after 30
minutes pre incubation.
4. Discussion
Because natural products of higher plants may give a new
source of medication, there are many research groups that
are now engaged in medicinal plants research not only for
the discovery for new drugs but possibly for discovering
compounds with novel mechanisms of action that can
stimulate new ﬁelds of research [23]. Furthermore and
considering the high cost of conventional antivenoms and
the signiﬁcant percentage (80%) of patients who react
adversely to them [26, 27], a systematic investigation of
plant-based remedies for snake bite is justiﬁed. Plants
used as remedy for snakebite abound in literature [28–
31]. However, many of the reported studies lack detailed
scientiﬁc investigation, which is needed in the development
of medicinal agents from plants [28, 30]. Research to develop
a treatment for local envenoming is a clinical priority and
has focused on the application of natural [21] or synthetic
inhibitors [22] of snake venom metalloproteinases (SVMPs)
and understanding the pathological role of SVMP-activated
proinﬂammatory cytokines [32–34].
In this study we have used one of the main traditional
herbal plants called Hibiscus aethiopicus which is used as
phytotherapy practiced by a large proportion of the Yemen
populationforthetreatmentofseveralclinicalcomplications
such as physical, physiological, mental, and social ailments
[23] as well as snake envenomation. In comparison to other
plants that were adequately investigated worldwide there
is little scientiﬁc research done to investigate generally the
plantsofYemenwhichareusedinherbalmedicine.However,
no scientiﬁc reports were found for Hibiscus aethiopicus and
its capacity to neutralized snake venom(s). Therefore, this
study represents the ﬁrst report about Hibiscus aethiopicus
and its uses as antivenom agent. To examine such neutrali-
sation eﬃcacy, two venoms from two diﬀerent snake species
(E. ocellatus and Naja n. nigricollis) were used. Prior to such
examination, the toxicity eﬀect of the Hibiscus aethiopicus
extract was examined on animals using in vivo assays based
on “oral” and “intra-peritoneal” administration routes.
The results of the oral route when compared to a general
acute toxicity index showed normal with no extraordinary
syndromes as well as no acute toxicity. However, both
routes showed that no death was recorded even at the
highest tested dose (16mg/kg). This was supported further
by the biochemical analysis as shown in Table 2.H o w e v e r ,
results from the intraperitoneally route showed initially dull
with signiﬁcantly reduced movement of the guinea pigs for
about 10–20 minutes. In the subsequent experiments we
used the Hibiscus aethiopicus extract to assess its eﬃcacy
to neutralise the haemorrhagic activity of E. ocellatus and
Naja n. nigricollis venoms using an in vivo minimum
haemorrhagic dose (MHD) assay utilised to preclinically
assess new antivenoms.
It was interesting to note that results of the evaluation
assays of anti-snake venom activity showed that Hibiscus6 Journal of Toxicology
aethiopicusinducessigniﬁcantneutralisationcapacityagainst
venom of E. ocellatus compared to that of Naja n. nigricollis
venom which showed no antivenom activity at all, as all
guinea pigs treated with a preincubation mixture of Naja
n. nigricollis venom and the extract died. There was no
signiﬁcantdiﬀerencebetweenthetimeofdeathinthetreated
and control groups. These results were conﬁrmed further by
the cytotoxicity assay.
The Hibiscus aethiopicus extract signiﬁcantly blocked
many of the toxic eﬀects of E. ocellatus venom in vitro.
Remarkably, the extract could not block the neurotoxic
activities of Naja n. nigricollis (results not shown) venom
on chicken blastodermal cells (cbcs) muscle preparation
whether the former was added three minutes before or after
the venom when the venom’s eﬀects on the preparation are
normally irreversible by three times washout of the venom.
Although the component(s) of the plant extract respon-
sible for the antivenom activity observed in the present
study has not yet been identiﬁed to verify the complete
absence or present of tannins, particularly low molecular
weight polyphenolic (epi-gallocatechin, epi-catechin etc.)
and a long-chain ester of transferulicacid, we presume that it
is unlikely that the antivenom activity is due to polyphenolic
components. Moreover, in comparison with the antivenom
activity of the extract on the E. ocellatus venom to that
of Naja n. nigricollis, it can be observed that it is not
possibletobeduetotheextractactingthroughamechanistic
intervention rather than a direct physical interaction with
the venom in vitro. This is similar to the mode of action of
many polyphenolic compounds found in plant extracts. This
prospect was conﬁrmed partially by the extract “protective”
eﬀects of plant extract when they are preincubated with E.
ocellatusvenombeforeadministrationtothebiologicalassay.
Therefore, to validate the above speculation(s) future work is
necessary to isolate and examine such component(s).
Another positive attribute of the extract is its anti-
haemorrhagic activity against E. ocellatus venom. We have
clearly shown that the extract is very eﬀective against the
activity of E. ocellatus venom in the circulatory system.
These ﬁndings reﬂect that the extract of Hibiscus aethiopicus
plant may contain an endogenous inhibitor of venom-
induced haemorrhage. This obviously would need further
investigations.
Despite these protective eﬀects of the plant extract of the
Hibiscus aethiopicus in vitro, the results obtained from the in
vivo experiments were highly encouraging. The extract did
protect animals challenged with lethal doses of the E. ocella-
tus venom when the extract and venom were administered
independently. Moreover, the extract did not protect animals
challenged with lethal doses of the Naja n. nigricollis venom
when extract and venoms were administered independently.
However, haemorrhage induction was signiﬁcantly reduced
(correlated with the increased of the extract concentration)
withanincreaseinthesurvivaltimeoftheguineapigstreated
with a mixture of the extract and the E. ocellatus venom after
30min of preincubation. In addition, none of the guinea
pigs treated with a mixture of Naja n. nigricollis venom and
the extract Hibiscus aethiopicus survived. Possibly the plant
extract could be eﬀective against viper snake that is, Naja n.
nigricollis, venom activity in vivo if the experiment model
is modiﬁed to stimulate actual life experience. In order to
obtain more positive results two possible considerations are
suggested for future work; ﬁrst the dose of venom should
be adjusted to achieve 75% instead of 100% mortality in
the control animal to ensure that they are not challenged
with very high dose of venom beyond the dose that any
snake can inject into its victim. A very high dose may not
give enough time for the extract to induce its antivenom
eﬀect. The other suggestion is to give repeated doses of the
extract at various time intervals (include an administration
of the extract immediately after venom injection), which
approximate to what obtains when humans are treated for
snakebite.Therefore,thiscanreﬂectthetherapeuticpotential
of the extract. Treatment is normally continued until clinical
signs of the envenomation disappear.
As venom toxicity within the same species varies and
very hard to standardize, the doses that we used in this
study to induce lethal eﬀects by both E. ocellatus and Naja
n. nigricollis were previously determined. The concept of the
venomtoxicityvariationiswelldocumentedintheliterature.
For instance, Ode and Asuzu (2006) [35] used diﬀerent
venom concentrations (to that we used) of 10mg/kg and
6mg/kg of E. ocellatus and Naja n. nigricollis,r e s p e c t i v e l y ,
to induce lethal eﬀects. Moreover, from our previous work
with E. ocellatus [36–38], for example, we have showed that
venom variation occurred both locally and from region to
region within the same species. Furthermore, Boche et al.
[39]a n dB r o a d l e[ 40] reported that snakes of the Naja n.
nigricollis species have variation in their neurotoxin content
both qualitative and quantitative.
Finally, future works are necessary. First we have to
perform a fractionation(s) assay of the Hibiscus aethiopicus
extract, so that the eﬀective component(s) responsible for
the inhibitory eﬀect can be identiﬁed. Subsequently, this will
allow us to perform the classical toxicity and neutralisation
assays including the lethal dose (LD50) of the venom as well
as to calculate the eﬀective dose (ED50) of the extract.
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